Secondary Analysis - Tandem t:slim X2 User Manual

CHAPTER 32 • Overview of Control-IQ Technology Clinical Studies

32.7 Secondary Analysis

The following table compares the percent of time that participants spent at the indicated sensor glucose levels during the daytime
and nighttime. The definitions of daytime and nighttime differ slightly between the two studies and are defined in the tables.
DCLP3: Secondary Analysis by Time of Day (N=168)
Characteristic Unit of Measure
Average Sensor Glucose
(std dev)
Overall Sensor
Average % Sensor Glucose 70 – 180
Glucose Control
mg/dL
(std dev)
DCLP5: Secondary Analysis by Time of Day (N=101)
Characteristic Unit of Measure
Average Sensor Glucose
(std dev)
Overall Sensor
Average % Sensor Glucose 70 – 180
Glucose Control
mg/dL
(std dev)
306
Daytime
Control-IQ SAP
158 mg/dL 170 mg/dL
(20 mg/dL) (26 mg/dL)
69.8% 59.4%
(12.4%) (14.6%)
Daytime
Control-IQ SAP
167 mg/dL 179 mg/dL
(21 mg/dL) (27 mg/dL)
63% 56%
(11%) (14%)
Nighttime
Control-IQ SAP
150 mg/dL 170 mg/dL
(18 mg/dL) (27 mg/dL)
76.1% 58.5%
(12.4%) (16.2%)
Nighttime
Control-IQ SAP
146 mg/dL 180 mg/dL
(16 mg/dL) (27 mg/dL)
80% 54%
(9%) (16%)